Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion
OTCMKTS:MKGAF

Merck KGaA Q2 2024 Earnings Results & Report

Merck KGaA logo
$167.21 +9.24 (+5.85%)
As of 10/20/2026 03:55 PM Eastern

Merck KGaA reported Q2 2024 earnings on August 1, 2024. The company reported EPS of $1.51, while revenue was $5.76 billion.

Earnings Announcement Details

Quarter
Q2 2024
Report Date

Merck KGaA EPS Results

Actual EPS
$1.51
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Merck KGaA Revenue Results

Actual Revenue
$5.76 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Merck KGaA's next earnings date is estimated for Thursday, November 12, 2026, based on past reporting schedules.

Conference Call Resources

Merck KGaA Q2 2024 Earnings FAQ

Merck KGaA (OTCMKTS:MKGAF) reported earnings of $1.51 per share for Q2 2024. The report was announced on Thursday, August 1, 2024.

Merck KGaA reported revenue of $5.76 billion for Q2 2024.

Merck KGaA's next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Merck KGaA on the company's earnings history page.

Merck KGaA Earnings Headlines

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down - Time to Sell?
See More Merck KGaA Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Merck KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck KGaA and other key companies, straight to your email.

About Merck KGaA

Merck KGaA (OTCMKTS:MKGAF) is a German science and technology company headquartered in Darmstadt, Germany. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The company operates under the name EMD Serono in the United States and Canada, where the Merck name is associated with a separate company.

Merck KGaA operates through three primary business sectors: Healthcare, Life Science and Electronics. Its Healthcare business develops and markets prescription medicines, including treatments in oncology, neurology and immunology, as well as fertility and other specialty-care products. The Life Science business supplies laboratory products, equipment, services and technologies used in pharmaceutical manufacturing, biotechnology, research and academic laboratories.

The Electronics business develops materials and solutions for the semiconductor and display industries, including specialty chemicals, semiconductor materials and liquid-crystal technologies. Merck KGaA serves customers in markets around the world through research, manufacturing and commercial operations across multiple regions. Belén Garijo has served as the company’s chief executive officer and chair of its executive board since 2021.

View Merck KGaA Profile